These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 3215198

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Growth hormone therapy in pre-pubertal children with Noonan syndrome: first year growth response and comparison with Turner syndrome.
    De Schepper J, Otten BJ, François I, Bourguignon JP, Craen M, Van der Burgt I, Massa GG.
    Acta Paediatr; 1997 Sep; 86(9):943-6. PubMed ID: 9343272
    [Abstract] [Full Text] [Related]

  • 4. Growth in Noonan syndrome.
    Otten BJ, Noordam C.
    Horm Res; 2009 Dec; 72 Suppl 2():31-5. PubMed ID: 20029234
    [Abstract] [Full Text] [Related]

  • 5. Growth curves for height in Noonan syndrome.
    Witt DR, Keena BA, Hall JG, Allanson JE.
    Clin Genet; 1986 Sep; 30(3):150-3. PubMed ID: 3780030
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Short stature in Noonan syndrome: response to growth hormone therapy.
    Kirk JM, Betts PR, Butler GE, Donaldson MD, Dunger DB, Johnston DI, Kelnar CJ, Price DA, Wilton P, Group tU.
    Arch Dis Child; 2001 May; 84(5):440-3. PubMed ID: 11316696
    [Abstract] [Full Text] [Related]

  • 9. Growth patterns of patients with Noonan syndrome: correlation with age and genotype.
    Cessans C, Ehlinger V, Arnaud C, Yart A, Capri Y, Barat P, Cammas B, Lacombe D, Coutant R, David A, Baron S, Weill J, Leheup B, Nicolino M, Salles JP, Verloes A, Tauber M, Cavé H, Edouard T.
    Eur J Endocrinol; 2016 May; 174(5):641-50. PubMed ID: 26903553
    [Abstract] [Full Text] [Related]

  • 10. Improved final height with long-term growth hormone treatment in Noonan syndrome.
    Osio D, Dahlgren J, Wikland KA, Westphal O.
    Acta Paediatr; 2005 Sep; 94(9):1232-7. PubMed ID: 16203673
    [Abstract] [Full Text] [Related]

  • 11. PTPN11 mutations are associated with mild growth hormone resistance in individuals with Noonan syndrome.
    Binder G, Neuer K, Ranke MB, Wittekindt NE.
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5377-81. PubMed ID: 15985475
    [Abstract] [Full Text] [Related]

  • 12. Noonan syndrome: a case report.
    Nirmal T, Muthu MS, Arranganal P.
    J Indian Soc Pedod Prev Dent; 2001 Jun; 19(2):77-9. PubMed ID: 11692827
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Growth hormone therapy in Noonan syndrome: growth response and characteristics.
    Westphal O.
    Horm Res; 2009 Dec; 72 Suppl 2():41-5. PubMed ID: 20029236
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Growth curves in untreated Ullrich-Turner syndrome: French reference standards 1-22 years.
    Sempé M, Hansson Bondallaz C, Limoni C.
    Eur J Pediatr; 1996 Oct; 155(10):862-9. PubMed ID: 8891555
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Growth hormone secretory status in patients with Turner syndrome.
    Zhang DH, Yano K, Itoh Y, Mitamura R, Suzuki N, Okuno A.
    Acta Paediatr Jpn; 1992 Jun; 34(3):282-9. PubMed ID: 1509873
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.